1. Department of Health Policy, London School of Economics and Political Science, London, United Kingdom
2. Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
3. Department of Oncology and Department of Public Health Sciences, Division of Cancer Care and Epidemiology, Queen’s University, Kingston, Canada